Prescription drug · ANDA
Naloxone Hydrochloride NDC 71872-7177
Naloxone hydrochloride 1 mg/mL · Injection · Parenteral · Medical Purchasing Solutions, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71872-7177-1 | 71872717701 | 1 SYRINGE in 1 BAG (71872-7177-1) / 2 mL in 1 SYRINGEMarketed from Sep 9, 2019 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Naloxone Hydrochloride
- Generic name (nonproprietary)
- naloxone hydrochloride
- Active ingredients
- Naloxone hydrochloride — 1 mg/mL
- Dosage form
- Injection
- Route
- Parenteral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 072076
- Marketing start
- Listing expires
- Other FDA classes
- Opioid Antagonists (Mechanism)
- Identifiers
- Product ID 71872-7177_fbbce2ae-1daa-b037-e053-6394a90a3397SPL ID fbbce2ae-1daa-b037-e053-6394a90a3397SPL set ID 958577c3-d2c4-26ad-e053-2a95a90ad73aRxCUI 1191250UNII F850569PQR
- Pharmacologic class
- Opioid Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N471872717701followed by a unit qualifier and the quantityPackage 71872-7177-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Naloxone hydrochloride injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including, propoxyphene, methadone and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine and butorphanol and cyclazocine. Naloxone hydrochloride is also indicated for the diagnosis of suspected or known acute opioid overdosage. Naloxone hydrochloride injection may be useful as an adjunctive agent to increase blood pressure in the management of septic shock. (see CLINICAL PHARMACOLOGY ; Adjunctive Use in Septic Shock ).
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 072076
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Naloxone Hydrochloride | Naloxone hydrochloride 1 mg/mL | InjectionParenteral | International Medication Systems, Limited | 76329-1469 |
| Naloxone Hydrochloride | Naloxone hydrochloride 1 mg/mL | InjectionParenteral | International Medication Systems, Limited | 76329-3369 |
| Naloxone Hydrochloride | Naloxone hydrochloride 1 mg/mL | InjectionParenteral | International Medication Systems, Limited | 76329-3469 |
| Naloxone Hydrochloride | Naloxone hydrochloride 1 mg/mL | InjectionParenteral | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1239 |
| Naloxone Hydrochloride | Naloxone hydrochloride 1 mg/mL | InjectionParenteral | Medical Purchasing Solutions, LLC | 71872-7294 |
| Naloxone Hydrochloride | Naloxone hydrochloride 1 mg/mL | InjectionParenteral | Henry Schein, Inc | 0404-9922 |
| Naloxone Hydrochloride | Naloxone hydrochloride 1 mg/mL | InjectionParenteral | REMEDYREPACK INC. | 70518-2725 |